Acquis et perspectives dans le traitement de l’insuffisance cardiaque

Ziskind, 2004, La conception du coeur dans l’Égypte ancienne, Médecine sciences, 20, 367, 10.1051/medsci/2004203367 Ackernecht, 1982 Sournia, 1997 The CONSENSUS Trial Study Group, 1987, Effects of enalapril on mortality in severe congestive heart failure, N Engl J Med, 316, 1429, 10.1056/NEJM198706043162301 Waagstein, 1993, Beneficial effects of metoprolol in idiopathic dilated cardiomyopathy: Metoprolol in Dilated Cardiomyopathy (MDC) Trial Study Group, Lancet, 342, 1441, 10.1016/0140-6736(93)92930-R Pitt, 1999, The effect of spironolactone on morbidity and mortality in patients with sévère heart failure: randomized Aldactone Evaluation Study Investigators, N Engl J Med, 341, 709, 10.1056/NEJM199909023411001 Pfeffer, 2003, Effects of candesartan on mortality and morbidity in patients with chronic heart failure: the CHARM-Overall programme, Lancet, 362, 759, 10.1016/S0140-6736(03)14282-1 Bristow, 2004, Comparison of Medical Therapy, Pacing, and Defibrillation in Heart Failure (COMPANION) Investigators. Cardiac-resynchronization therapy with or without an implantable defibrillator in advanced chronic heart failure, N Engl J Med, 350, 2140, 10.1056/NEJMoa032423 Cleland, 2005, The effect of cardiac resynchronization on morbidity and mortality in heart failure, N Engl J Med, 352, 1539, 10.1056/NEJMoa050496 Ho, 1993, The epidemiology of heart failure: the Framingham study, J Am Coll Cardiol, 22, 6, 10.1016/0735-1097(93)90455-A Owan, 2006, Trends in prevalence and outcome of heart failure with preserved ejection fraction, N Engl J Med, 355, 251, 10.1056/NEJMoa052256 McAlister, 2004, Multidisciplinary strategies for the management of heart failure patients at high risk for admission: a systematic review of randomized trials, J Am Coll Cardiol, 44, 810 Dickstein, 2008, ESC guidelines for the diagnosis and treatment of acute and chronic heart failure 2008: the Task Force for the diagnosis and treatment of acute and chronic heart failure 2008 of the European Society of Cardiology, Eur J Heart Fail, 10, 933, 10.1016/j.ejheart.2008.08.005 Tavazzi, 2008, Effect of n-3 polyunsaturated fatty acids in patients with chronic heart failure (the GISSI-HF trial): a randomised, double-blind, placebo-controlled trial, Lancet, 372, 1223, 10.1016/S0140-6736(08)61239-8 Massie, 2008, Irbesartan in patients with heart failure and preserved ejection fraction, N Engl J Med, 359, 2456, 10.1056/NEJMoa0805450 Miller, 2007, Use of a continuous-flow device in patients awaiting heart transplantation, N Engl J Med, 357, 885, 10.1056/NEJMoa067758